Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $1.61 million. The enterprise value is $15,466.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 2.13 million shares outstanding. The number of shares has increased by 168.54% in one year.
| Current Share Class | 2.13M |
| Shares Outstanding | 2.13M |
| Shares Change (YoY) | +168.54% |
| Shares Change (QoQ) | +15.18% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 6.66% |
| Float | 2.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 26.92 |
| P/TBV Ratio | 27.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 1.81.
| Current Ratio | 1.01 |
| Quick Ratio | 0.79 |
| Debt / Equity | 1.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -300.16% and return on invested capital (ROIC) is -180.23%.
| Return on Equity (ROE) | -300.16% |
| Return on Assets (ROA) | -98.32% |
| Return on Invested Capital (ROIC) | -180.23% |
| Return on Capital Employed (ROCE) | -9,183.39% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.79M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.08% in the last 52 weeks. The beta is 0.42, so SLRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -79.08% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 1.40 |
| Relative Strength Index (RSI) | 52.11 |
| Average Volume (20 Days) | 24,756 |
Short Selling Information
The latest short interest is 52,652, so 2.48% of the outstanding shares have been sold short.
| Short Interest | 52,652 |
| Short Previous Month | 84,158 |
| Short % of Shares Out | 2.48% |
| Short % of Float | 2.52% |
| Short Ratio (days to cover) | 1.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.68M |
| Pretax Income | -6.46M |
| Net Income | -5.57M |
| EBITDA | -5.68M |
| EBIT | -5.68M |
| Earnings Per Share (EPS) | -$4.47 |
Full Income StatementBalance Sheet
The company has $1.80 million in cash and $112,230 in debt, giving a net cash position of $1.69 million or $0.79 per share.
| Cash & Cash Equivalents | 1.80M |
| Total Debt | 112,230 |
| Net Cash | 1.69M |
| Net Cash Per Share | $0.79 |
| Equity (Book Value) | 61,866 |
| Book Value Per Share | 0.03 |
| Working Capital | 27,560 |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.35M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.35M |
| FCF Per Share | -$2.05 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |